深度大脑刺激可以阻止与帕金森病相关的免疫失调在大脑和周围血液中
Rhonda L McFleder1, Thomas Musacchio1, Johanna Keller1
1Department of Neurology, University Hospital of Würzburg, Würzburg, Germany.
Brain, behavior, and immunity
|October 31, 2024
概括
循环淋巴细胞在帕金森病 (PD) 中下降,并预测运动进展. 深度大脑刺激 (DBS) 可能通过转移免疫细胞和减少大脑炎症来逆转这种下降,这表明它具有疾病修饰作用.
科学领域:
- 神经免疫学 神经免疫学
- 神经退行性疾病的神经退行性疾病
- 帕金森病的研究研究.
背景情况:
- 大脑和外围的免疫失调与帕金森病 (PD) 神经退行有关.
- 目前PD的治疗方法主要是治疗症状,强调了改变疾病的治疗方法的必要性.
- 了解免疫机制对于开发有效的PD治疗方法至关重要.
研究的目的:
- 调查循环淋巴细胞在PD进展中的作用.
- 为了确定深度大脑刺激 (DBS) 是否影响PD中的免疫失调.
- 探索DBS作为帕金森病的疾病修饰疗法的潜力.
主要方法:
- 来自帕金森病进展标志物倡议 (PPMI) 队列的纵向数据的分析.
- 在PD患者中,免疫细胞群 (CD4+ T辅助细胞17和CD4+调节性T细胞) 的表征.
- 在PD的A53Tα-synuclein大鼠模型中的RNA测序和免疫组织化学.
主要成果:
- 循环淋巴细胞在PD患者中逐渐下降,并预测未来的运动症状进展.
- 深度大脑刺激 (DBS) 与淋巴细胞减少的停止有关.
- DBS使免疫平衡从亲炎性T辅助17细胞转变为抗炎性调节性T细胞,并减少了PD大鼠模型中的神经炎症.
结论:
- 循环淋巴细胞的逐渐下降是PD运动进展的生物标志物.
- 通过调节免疫反应和减少神经炎症,DBS可能会产生改变疾病的效果.
- 这些发现表明DBS的潜在治疗作用超出了帕金森病的症状缓解.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
224
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
224
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview
483
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
483


